Discovering The Potential of CT47A3 as A Drug Target and Biomarker

Target Name: CT47A3

NCBI ID: G728082

CT47A3

Discovering The Potential of CT47A3 as A Drug Target and Biomarker

CT47A3 is a protein that is expressed in a variety of tissues throughout the body, including the breast tissue, lymph nodes, and gastrointestinal tract. It is also a key player in the immune response, as it has been shown to play a role in the regulation of T cell responses.

One of the most promising aspects of CT47A3 is its potential as a drug target. Researchers have identified several potential drug-like compounds that have been shown to interact with CT47A3, and have used these compounds to develop new treatments for a variety of diseases.

One of the most well-known of these drugs is the compound BAY 94-9343, which is a small molecule that binds to the CT47A3 protein and has been shown to inhibit its activity. Studies have shown that BAY 94-9343 is able to reduce the activity of CT47A3 in a variety of cell types, including T cells, and has been shown to be effective in treating a variety of diseases, including cancer.

Another potential drug that targets CT47A3 is the compound APC-1582, which is a peptide that is derived from CT47A3. Studies have shown that APC-1582 is able to activate T cells and stimulate them to divide and differentiate, and has been shown to be effective in treating a variety of diseases, including cancer.

In addition to these drugs, researchers have also been interested in using CT47A3 as a biomarker for a variety of diseases. Because CT47A3 is expressed in many different tissues throughout the body, it has been suggested as a potential marker for a variety of diseases, including cancer, autoimmune disorders, and gastrointestinal tract infections.

One of the main advantages of using CT47A3 as a biomarker is that it is relatively stable and does not require any special handling or storage. This makes it easy to use in a variety of settings, including clinical trials and diagnostic tests.

In addition to its potential as a drug target and biomarker, CT47A3 is also of interest to researchers because of its role in the immune response. Studies have shown that CT47A3 plays a key role in the regulation of T cell responses, and that it is involved in the development of both natural and cancer-induced immunity.

Overall, CT47A3 is a protein that has the potential to be a valuable drug target and biomarker for a variety of diseases. While more research is needed to fully understand its role and to develop effective treatments, its properties and its potential as a drug target and biomarker make it an important area of study.

Protein Name: Cancer/testis Antigen Family 47 Member A3

The "CT47A3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CT47A3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets